Skip to main content

Animations

MJFF Publications

2081 - 2090 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2011
  • 2023
  • 2024
  • 2019
  • 2018
  • 2023
  • 2025
  • 2008
  • 2022
  • Summary Details
    OPEN
    Title: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170803
    Citation Count: 160
  • Summary Details
    OPEN
    Title: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2
    Citation Count: 325
  • Summary Details
    OPEN
    Title: Journal Production Guidance for Software and Data Citations
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02491-7
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Profiling complex repeat expansions in RFC1 in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00723-0
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmet.2017.12.008
    Citation Count: 534
  • Summary Details
    OPEN
    Title: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Journal Name: Diabetes Care
    Publisher: American Diabetes Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2337/dc22-1705
    Citation Count: 92
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.